Results 161 to 170 of about 5,674 (178)

Influence of piperine and omeprazole on the regional absorption of Daclatasvir from rabbit intestine

Biopharmaceutics and Drug Disposition, 2022
Ebtessam Essa, Shimaa Ashmawy
exaly  

Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis

Journal of Infection, 2021
Chih-Cheng Lai, Chien-Ming Chao
exaly  

Asunaprevir/daclatasvir

Reactions Weekly, 2019
openaire   +1 more source

Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis

Journal of Antimicrobial Chemotherapy, 2021
Anahita Sadeghi, Hafez Fakheri, Andrew M Hill   +2 more
exaly  

Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin

International Journal of Infectious Diseases, 2016
Lorenzo Messa, Giorgio Palu, Saverio Parisi   +2 more
exaly  

Daclatasvir/sofosbuvir

Reactions Weekly, 2022
openaire   +1 more source

Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma

Journal of Pharmaceutical and Biomedical Analysis, 2017
Lorenzo Messa, Giorgio Palu, Saverio Parisi   +2 more
exaly  

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late

Digestive and Liver Disease, 2014
Adriano Pellicelli, Gianpiero D'Offizi, Marzia Montalbano   +2 more
exaly  

Daclatasvir/Sofosbuvir

Reactions Weekly
openaire   +2 more sources

Population Pharmacokinetic Analysis for Daclatasvir and Asunaprevir in Japanese Subjects With Chronic Hepatitis C Virus Infection

Journal of Clinical Pharmacology, 2018
Tushar Garimella
exaly